Sorrento Therapeutics Inc (SRNE)

[dia76ca]

The Sorrento mRNA vaccine can be expected to have the 90+% efficacy of other mRNA vaccines but have two important advantages. It will NOT require a cold-chain. It will however be MORE effective against the new more agressive and more lethal variants. Both of these advantages are significant!

I understand that J&J has a viral vector vaccine that does not require a cold-chain. However it is only 66% effective, unlikely to handle the variants, and has the following rather scary warning from the CDC.
"Johnson & Johnson’s Janssen (J&J/Janssen) COVID-19 Vaccine: The Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration (FDA) recommended that use of (J&J/Janssen) COVID-19 Vaccine resume in the United States, effective April 23, 2021. However, women younger than 50 years old should especially be aware of the rare risk of blood clots with low platelets after vaccination. There are other COVID-19 vaccines available for which this risk has not been seen."